Viewing Study NCT00827203


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-05-10 @ 9:51 AM
Study NCT ID: NCT00827203
Status: SUSPENDED
Last Update Posted: 2009-03-09
First Post: 2009-01-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Sponsor: Synta Pharmaceuticals Corp.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None metastatic View
None Elesclomol Sodium View
None tumor View
None Advanced solid tumors that are metastatic and unresectable View